無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

薬用スキンケア用品の世界市場

Medicated Skin Care Products

発行 Global Industry Analysts, Inc. 商品コード 243080
出版日 ページ情報 英文 342 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.61円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
薬用スキンケア用品の世界市場 Medicated Skin Care Products
出版日: 2018年04月01日 ページ情報: 英文 342 Pages
概要

当レポートでは、薬用スキンケア用品の世界市場に注目し、今後の取引価額の推移を予測し、現在の市況を地域(米国、カナダ、日本、欧州、アジア太平洋地域、ラテンアメリカ、その他)に分けて考察するほか、過去6年にわたる市場動態データや現在活躍している大小参入企業のプロファイルなど競合環境に関する調査情報をまとめています。

第1章 イントロダクション、調査方法、製品の定義

  • 調査の信頼性とレポートの限界
  • 免責事項
  • データの解釈とレポート作成レベル
    • 定量技法と分析
  • 製品の定義と調査範囲

第2章 エグゼクティブサマリー

  • 産業概要
    • 薬用スキンケア用品 - 肌の健康ニーズに対する医学的ソリューション
    • 美容と健康管理の結合
    • 成長推進要因を概説する
    • 皮膚病の広がりと処置に関するアンメットニーズ - 基盤となる成長推進要因
    • 主な皮膚病 - すぐに思いつく数件の事例
    • 世界市場展望
    • 先進国市場 - 従来の収入源
    • 引き続き大幅成長の機会をもたらす開発途上国市場
    • 競合状況
    • 薬用スキンケア用品世界市場の主要参入企業
    • 協力を重視する各供給企業
    • M&A(事業統合・買収)活動
  • 市場の動向、課題、推進要因
    • 医療費上昇の中で強まる健康と自己管理重視の姿勢で成長を加速する健康市場
    • デルモコスメティクス需要に弾みを付ける健康問題
    • 老齢化人口と加齢による皮膚編成に対する同層の脆弱性 - 強力な成長推進要因
    • 薬用化粧品の主なアンチエージング成分
    • 人気の高い薬用化粧品成分
    • 世界の老齢化大衆の人口階層統計値
    • アンチエージングスキンケア用品への需要急増が市場への吉兆に
    • 一般的なスキンケア薬用化粧品
    • パーソナル化スキンケア処方への好感度上昇が市場浸透に寄与
    • 非処方製品の失敗で高まる医師処方スキンケアソリューションへの需要
    • 薬用スキンケア用品の技術革新 - 成長を先導するもの
    • にきび治療の技術革新
    • 光線角化症治療の技術革新
    • 結節性硬化症および血管線維腫治療の技術革新
    • 黒皮症治療の技術革新
    • 爪甲真菌症治療の技術革新
    • 脱毛・抜け毛治療の技術革新
    • 幹細胞技術 - 新たなフロンティアか
    • 有効成分識別に向けたインテリジェントスキャニング
    • アンチエージングスキンケアにおける技術革新
    • その他の注目すべき薬用スキンケアの新技術
    • 天然成分に対する消費者の関心に支えられる天然・有機製品需要
    • 次代の新成分
    • 注目を呼ぶ革新的成分
    • 持続的成長を見せる美容皮膚科学
    • 美容産業全般への追い風がもたらす薬用スキンケア用品市場発展の契機
    • 市場拡大を促す多機能製品の人気急増
    • 弾みを増すヒドロキノン不使用製品の販売
    • フェイシャルワイプに秘められた手付かずの巨大な成長性
    • 女性 - 薬用スキンケア用品の主流を成す消費者層
    • 男性専門用品ニーズを引き起こする生理学的差異
    • 非侵襲性皮膚治療への好感度上昇で弾みを増す市場需要
    • 環境汚染拡大で需要が高まる反汚染スキンケア用品
    • 薬用スキンケア用品の需要増を促す都市型汚染の急拡大
  • 規制の枠組み
  • 製品概要
  • 製品発売・認可
  • 最新産業動向
  • 世界の主要参入企業
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • スペイン
    • ロシア
    • その他欧州
  • アジア太平洋地域
    • 中国
    • インド
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ
  • その他の地域

競合環境

目次
Product Code: MCP-5091

This report analyzes the worldwide markets for Medicated Skin Care Products in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 120 companies including many key and niche players such as -

Advanced Dermatology Corporation
Bayer AG
Beiersdorf AG
Chattem, Inc.
Curatio Healthcare India Pvt. Ltd.
EltaMD, Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Medicated Skin Care Products: Medical Solutions for Skin Health Needs
  • Convergence of Beauty and Healthcare
  • Growth Drivers in a Nutshell
  • Growing Prevalence of Skin Diseases and the Unmet Treatment Needs: A Fundamental Growth Driver
  • Major Skin Diseases: Few Fast Facts
  • Global Market Outlook
  • Developed Markets: Traditional Revenue Contributors
  • Developing Countries Continue to Offer Significant Growth Opportunities
    • Table 1: Global Medicated Skin Care Products Market - Geographic Regions Ranked by CAGR (Value Sales) for 2015-2022: Asia-Pacific, Rest of World, Latin America, USA, Canada, Europe, and Japan (includes corresponding Graph/Chart)
  • Competitive Scenario
  • Leading Players in the Global Medicated Skin Care Products Market
  • Vendors Emphasize Collaborations
  • M&A Activity

2. MARKET TRENDS, ISSUES & DRIVERS

  • Increasing Focus on Wellness and Self-Care amidst Mounting Healthcare Costs Drive Healthy Market Growth
  • Health & Wellness Boosts Demand for Dermocosmetics
  • Aging Population and their Vulnerability to Age-Related Skin Changes: A Strong Growth Driver
  • Major Anti-Aging Ingredients of Cosmeceuticals
  • Popular Cosmeceutical Contents
  • Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential
    • Table 2: Global Aging Population (in Thousands) by Age Group: 1975-2050 (includes corresponding Graph/Chart)
    • Table 3: Global Population by Age-Group: Percentage Change Over the Period 2010-2050 (includes corresponding Graph/Chart)
    • Table 4: Global Aging Population in Select Regions/ Countries: Population of 60+ Individuals in '000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
  • Booming Demand for Anti-Aging Skin Care Products Bodes Well for the Market
  • Common Skin Care Cosmeceuticals
  • Growing Prominence of Personalized Skin Care Prescriptions Benefit Market Penetration
  • Failure of Non-Prescription Products Drive Demand for Physician-Dispensed Skin Care Solutions
  • Medicated Skin Care Innovations: Spearheading Growth
  • Innovations for Acne
  • Innovations for Actinic Keratosis
  • Innovations for Tuberous Sclerosis Complex and Angiofibromas
  • Melasma Treatment Innovations
  • Onychomycosis Treatment Innovations
  • Innovations for Alopecia/Hair Loss
  • Stem Cell Technology: The New Frontier?
  • Intelligent Scanning for Identifying Beneficial Ingredients
  • Innovations in Anti-Aging Skin Care
  • Other Noteworthy Medicated Skin Care Innovations
  • Consumer Interest in Natural Ingredients Drive Demand for Natural and Organic Products
  • What's Next in Ingredients?
  • Innovative Ingredients Gain Focus
  • Aesthetic Dermatology to Witness Sustained Growth
  • Favorable Trends in the Beauty Industry Spell Opportunities for Medicated Skin Care Market
  • Surging Popularity of Multi-Functional Products Promote Market Expansion
  • Sales of Hydroquinone-free Products Gain Momentum
  • Facial Wipes Offers Huge Untapped Growth Potential
  • Women: The Dominant Consumer Cluster for Medicated Skin Care Products
  • Physiological Differences Entail Need for Male Specific Products
  • Growing Prominence of Non-Invasive Skin Treatments Lends Traction to Market Demand
  • Increasing Environmental Pollution Drive Demand for Anti-Pollution Skin Care Products
  • Exponential Increase in Urban Population Promote Higher Demand for Medicated Skin Care
    • Table 5: World Urban Population in Thousands: 1950-2050P (includes corresponding Graph/Chart)
    • Table 6: Degree of Urbanization Worldwide: Urban Population as a Percentage of Total Population by Geographic Region for the Years 1990, 2014 & 2050 (includes corresponding Graph/Chart)

3. REGULATORY FRAMEWORK

  • The Food, Drug, and Cosmetic Act (FD&C Act)
  • The Concept of "Intended Use"
  • Skin Care Products Continue to Dodge Stringent US FDA Regulations
  • Regulatory Differences for Skin Care Products and Drugs
  • FDA getting into the Act
  • National Advertising Division Concentrates on Big Three

4. PRODUCT OVERVIEW

5. PRODUCT LAUNCHES/APPROVALS

  • ZO(r) Skin Health Unveils Oclipse(r) Daily-Use Sun Protection Product
  • Skinvisible Develops New Topical and Transdermal Cannabis Products
  • NeoStrata Launches ProSystem Retinol Peel
  • SkinFix Launches ExtraStrength Adult Skincare Product & Eczema Treatment for Kids
  • Skinbetter Science Introduces Clinical Skin Care Line
  • Galderma Receives Positive Opinion from EU Regulatory Agencies for EPIDUO
  • Adigica Health Launches BioClarity(tm) Acne Treatment
  • FDA Approves Differin Gel 0.1% for OTC Acne Treatment
  • Medimetriks Submits NDA for Impetigo Treatment Cream
  • Ceramax Cream by IntraDerm Pharmaceuticals Receives FDA Clearance
  • FDA Accepts Anacor's NDA for Crisaborole Topical Ointment
  • Theraderm Launches New Anti-aging Skin Care System
  • Dapzone Gel by Allergan Receives FDA Approval for Acne Treatment
  • Bayer HealthCare Launches Finacea Foam for Rosacea Treatment
  • Galderma's SOOLANTRA(r) (ivermectin) Cream Approved for Rosacea Patients
  • Skinvisible Pharmaceuticals Expands Patent Portfolio
  • Valeant Receives NEA Seal of Approval for CeraVe Baby Products
  • Galderma Launches Benzac(r) OTC Acne Solutions
  • LETI Laboratories' AT4 System Launched in US

6. RECENT INDUSTRY ACTIVITY

  • ZO Skin Health Bags Global Rights to Suneva Medical's ReFissa(r)
  • Galderma Conducts Phase 4 Clinical Studies of New Restylane(r) Products
  • CCA Industries Inks License Agreement with Ultimark Products
  • L'Oreal Purchases Valeant's CeraVe, AcneFree and AMBI Skincare Brands
  • Otsuka Pharmaceutical to Construct New Facility
  • Shiseido Receives Regulatory Approval for New Retinol Formulation
  • Shiseido Acquires Gurwitch Products
  • Oculus Innovative Sciences Renames itself as Sonoma Pharmaceuticals
  • Taisho to Acquire KYORIN's Dr. Program Business
  • Galderma Receives USFDA Approval of Restylane(r) Refyne and Restylane(r) Defyne
  • Moberg Pharma to Acquire Prestige Brands' DermoPlast(r) Product Line
  • Nestle Skin Health and Pinetree Care Group Collaborate on Skin Care Pilot Study
  • Cadila Acquires Skincare Brand Melgain from Issar Pharma
  • Chugai and Galderma Enter into Global License Agreement
  • Pfizer Acquires Anacor Pharmaceuticals
  • Nestle Skin Health Enters into Agreement with Guthy-Renker LLC
  • Galderma Enters into Alliance with Maruho of Japan
  • Otsuka and Medimetriks Enter Into Licensing Agreement
  • Unilever to Acquire Clinical Skincare Brand Murad

7. FOCUS ON SELECT GLOBAL PLAYERS

  • Advanced Dermatology Corporation (USA)
  • Bayer AG (Germany)
  • Beiersdorf AG (Germany)
  • La Prairie Group AG (Switzerland)
  • Chattem, Inc. (USA)
  • Curatio Healthcare India Pvt. Ltd. (India)
  • Dr. med. Christine Schrammek Kosmetik GmbH & Co. KG (Germany)
  • EltaMD, Inc. (USA)
  • Episciences, Inc. (USA)
  • Galderma S.A. (Switzerland)
  • GlaxoSmithKline Plc (UK)
  • Stiefel Laboratories Inc. (USA)
  • IntraDerm(tm) Pharmaceuticals (USA)
  • Johnson & Johnson (USA)
  • Kao Corporation (Japan)
  • Laboratorios Leti SL. (Spain)
  • L'Oreal S.A. (France)
  • Medimetriks Pharmaceuticals, Inc. (USA)
  • Merz Pharma GmbH & Co. KGaA (Germany)
  • NEOCUTIS (USA)
  • Otsuka Pharmaceutical Co., Ltd. (Japan)
  • PCA Skin (USA)
  • Pfizer Inc. (USA)
  • Prestige Brands (USA)
  • Shiseido Co., Ltd. (Japan)
  • ReVive Skincare (USA)
  • SkinCeuticals (USA)
  • SkinMedica, Inc. (USA)
  • Skinvisible Pharmaceuticals, Inc. (USA)
  • Taisho Pharmaceuticals Co., Ltd. (Japan)
  • The Himalaya Drug Company (India)
  • Unilever NV (Netherlands)
  • Valeant Pharmaceuticals International, Inc. (Canada)
  • Obagi Medical Products, Inc. (USA)
  • Vivier Pharma (Canada)
  • ZO(r) Skin Health Inc. (USA)

8. GLOBAL MARKET PERSPECTIVE

    • Table 7: World Recent Past, Current & Future Analysis for Medicated Skin Care Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 8: World Historic Review for Medicated Skin Care Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 9: World 14-Year Perspective for Medicated Skin Care Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Aging Population: A Significant Demand Booster for the Medicated Skin Care Market
    • Table 10: Aging Population in the US (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
    • Table 11: North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
    • Baby-Boomers and Working Females Propel Demand for Medicated Skin Care Products
    • Natural Formulations Revive Growth in the Sluggish Skin Care Market
    • FDA Proposes Ban on Hydroquinone in Skin Care Products
    • Busy Lifestyles Spur Demand for Products with Anti-Stress Claims
    • Blemish Balms Attracts Attention
    • Competitive Landscape
    • Table 12: Leading Players in the US Dermatologicals Market (2016): Percentage Market Share Breakdown for Johnson & Johnson, Bayer, Sanofi, GSK, Pfizer, Prestige Brands and Others (includes corresponding Graph/Chart)
    • Product Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 13: US Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 14: US Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Anti-Aging Cosmeceuticals: A High Growth Segment
    • Table 15: Aging Population in Canada (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
    • Competitive Landscape
    • Table 16: Leading Players in the Canadian Dermatologicals Market (2016): Percentage Market Share Breakdown for McNeil Consumer, Bayer, Prestige Brands, and Others (includes corresponding Graph/Chart)
    • Product Launch
    • Corporate Development
    • Select Key Players
  • B. Market Analytics
    • Table 17: Canadian Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 18: Canadian Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Aging Population, Growing Awareness and Rising Women Workforce Drives Market Demand
    • Table 19: Aging Population in Japan (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
    • Regulatory Overview
    • Competitive Landscape
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 20: Japanese Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 21: Japanese Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • European Skin Care Market: A Macro Perspective
      • Despite Economic Woes, Anti-Aging Skin Care Market Continue to Witness Healthy Growth
    • Table 22: Aging Population in Europe by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 23: European Recent Past, Current & Future Analysis for Medicated Skin Care Products by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia and Rest of European Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 24: European Historic Review for Medicated Skin Care Products by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia and Rest of European Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 25: European 14-Year Perspective for Medicated Skin Care Products by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of European Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Competitive Landscape
    • Table 26: Leading Players in the French Dermatologicals Market (2016): Percentage Market Share Breakdown for Johnson & Johnson Sante Beaute, Laboratoires Pierre Fabre, Cooperation Pharmaceutique Francaise / Cooper and Others (includes corresponding Graph/Chart)
    • Key Player
  • B. Market Analytics
    • Table 27: French Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 28: French Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Competitive Landscape
    • Table 29: Leading Players in the German Dermatologicals Market (2016): Percentage Market Share Breakdown for GSK, Bayer, and Others (includes corresponding Graph/Chart)
    • Product Launch
    • Select Key Players
  • B. Market Analytics
    • Table 30: German Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 31: German Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 32: Italian Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 33: Italian Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Rising Demand for OTC Medicines Drive Market Growth
    • Table 34: UK OTC Drug Market by Category (2017E): Percentage Breakdown of Value Sales for Analgesics, Cough and Cold Preparations, Medicated Skin Care Products, and Others (includes corresponding Graph/Chart)
    • Table 35: UK OTC Skin Care Market by Category (2017E): Percentage Breakdown of Value Sales for Antifungals, Antiseptic Products, Cold Sore Treatments, Cystitis Treatments, Deworming/Delice Treatments, Dry Skin Treatments, Feminine Lubricants, Hemorrhoid Treatments, Insect Bite Treatments, Medicated Skincare, Scalp/Hair Treatments, and Wart Treatments (includes corresponding Graph/Chart)
    • Competitive Landscape
    • Table 36: Leading Players in the UK Dermatologicals Market (2016): Percentage Market Share Breakdown for Bayer, GlaxoSmithKline, and Others (includes corresponding Graph/Chart)
    • Corporate Development
    • Key Player
  • B. Market Analytics
    • Table 37: UK Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 38: UK Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Key Player
  • B. Market Analytics
    • Table 39: Spanish Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 40: Spanish Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 41: Russian Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 42: Russian Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Product Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 43: Rest of Europe Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 44: Rest of Europe Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Medicated Skin Brightening and Lightening Products: A High Growth Market
    • Asian Aesthetics Market
  • B. Market Analytics
    • Table 45: Asia-Pacific Recent Past, Current & Future Analysis for Medicated Skin Care Products by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 46: Asia-Pacific Historic Review for Medicated Skin Care Products by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 47: Asia-Pacific 14-Year Perspective for Medicated Skin Care Products by Geographic Region/Country - Percentage Breakdown of Dollar Sales for China, India, and Rest of Asia-Pacific Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Overview
    • OTC Drug Market
    • Table 48: Chinese OTC Drug Market by Category (2017E): Percentage Breakdown of Value Sales for Analgesics, Gastrointestinal Drugs, Medicated Skincare Products, Traditional Medicines, and Others (includes corresponding Graph/Chart)
    • Corporate Development
  • B. Market Analytics
    • Table 49: Chinese Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 50: Chinese Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

5b. INDIA

  • A. Market Analysis
    • Overview
    • Corporate Development
    • Select Key Players
  • B. Market Analytics
    • Table 51: Indian Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 52: Indian Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

5c. REST OF ASIA PACIFIC

  • A. Market Analysis
    • Select Regional Markets
      • Australia: Aging Population Drives the Dermatologicals Market
    • Table 53: Aging Population in Australia (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
      • South Korea
      • Taiwan: Skin Problems of Modern Consumers Spurs Market Demand
      • Thailand: Thai Beauty Ingredients Gain Popularity in the West
  • B. Market Analytics
    • Table 55: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 56: Rest of Asia-Pacific Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • Market Analysis
    • Table 57: Latin American Recent Past, Current & Future Analysis for Medicated Skin Care Products by Geographic Region/Country - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 58: Latin American Historic Review for Medicated Skin Care Products by Geographic Region/Country - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 59: Latin American 14-Year Perspective for Medicated Skin Care Products by Geographic Region/Country - Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin American Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

6a. BRAZIL

  • A. Market Analysis
    • Relatively Lesser Share of Medicated Skin Care in OTC Sales Spell Opportunities
    • Table 60: Brazilian OTC Drug Market by Category (2017E): Percentage Breakdown of Value Sales for Analgesics, Cough and Cold Preparations, Medicated Skincare Products, Vitamins and Minerals, and Others (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 61: Brazilian Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 62: Brazilian Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

6b. REST OF LATIN AMERICA

  • A. Market Analysis
    • Mexico: Competitive Landscape
    • Table 63: Leading Dermatologicals Players in Mexico (2016): Percentage Share Breakdown for Genomma Lab, Bayer de Mexico, and Others (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 64: Rest of Latin American Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 65: Rest of Latin American Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • United Arab Emirates: Increasing Consumer Willingness Drive Sales
    • Competitive Landscape
    • Table 66: Leading Dermatologicals Players in the UAE (2016): Percentage Share Breakdown for Bayer, J&J, GSK, and Others (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 67: Rest of World Recent Past, Current & Future Analysis for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 68: Rest of World Historic Review for Medicated Skin Care Products Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Back to Top